Lidocaine-prilocaine cream versus lidocaine injection top-up for pain relief during episiotomy repair after vaginal delivery in Maiduguri: A multi-centre randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202601683476117

Enrollment

138

Registered

2026-01-30

Start date

2026-03-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

Lidocaine prilocaine cream group

Lidocaine injection group B

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) Gestational age greater than or equal to 37 weeks 2) Singleton pregnancy 3) Cephalic presentation

Exclusion criteria

Exclusion criteria: 1) Epidural analgesia 2) Operative delivery 3) Previous adverse reaction to a local anaesthetic 4) Cervical tear 5) 3rd or 4th degree perineal tear 6) Neurological disease which affects the lower limb 7) Heart disease 8) Uncontrolled Diabetes mellitus

Design outcomes

Primary

Measure	Time frame
The primary outcome of this study is to determine and compare participants’ pain perception when either lidocaine-prilocaine cream or lidocaine infiltration is given for Top-up for pain relief during episiotomy repair following vaginal delivery.	—

Secondary

Measure	Time frame
The secondary outcome measures will be the need for rescue analgesia, duration of repair with each method, patient’s satisfaction, rate of adverse effects of both medications and post-partum complications (wound infection).	—

Countries

Nigeria

Contacts

Public ContactAbraham Okoihue

Drugfield pharmaceutical company drug representative

aokoihue@yahoo.com+2348063176288

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026